MuhamadAlhaj MoustafaMD, MS

PubMed

• 11 citations
  A Challenging Case of Pseudohyperkalemia in Chronic Lymphocytic Leukemia.
  Muhamad Alhaj Moustafa, Vera Malkovska, Sherif Elmahdy, Joseph P. Catlett
  Journal of Investigative Medicine High Impact Case Reports. 2017-12-13
• 14 citations
  Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient Care.
  Vivek A. Kumar, Muhamad Alhaj-Moustafa, Leyla Bojanini, Taimur Sher, Vivek Roy
  JCO Oncology Practice. 2020-01-21
• 11 citations
  Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma.
  Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish
  International Journal of Radiation Oncology, Biology, Physics. 2023-08-01

Journal Articles

• Medical Image of the Week: Malposition of Central Venous Catheter  
  Mohamad Muhailan, MD and Muhamad Alhaj Moustafa, MD, Southwest Journal of Pulmonary and Critical Care, 7/11/2018

Abstracts/Posters

• Outcomes of Hematopoietic Cell Transplantation for Hepatosplenic T-Cell Lymphoma: A US Multicenter Collaborative Study
  Muhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, Farhad Khimani, Bhagirathbhai Dholaria, Leyla Bojanini, Jasmine Zain, N Nora Bennani, Zachary Braunst..., Transplantation and Cellular Therapy, Orlando, FL, 2/1/2023
• Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+ Treated with Daratumumab-Based Regimens: A Retrospective Analysis
  Ricardo D Parrondo, Lindsay Brooke Gardner, Muhamad Alhaj Moustafa, Vivek Roy, Taimur Sher, Ahsan Rasheed, Rahma M Warsame, Jeremy T Larsen, Wilson I Gonsalves, Taxiar..., American Society of Hematology, 11/15/2022
• Clinical Characteristics, Survival Outcomes, and Prognostic Factors in Lymphocyte-Depleted Hodgkin's Lymphoma: National Cancer Database Analysis (2004-2018)
  Firas Baidoun, Bradford Hoppe, Han W Tun, Muhamad Alhaj Moustafa, American Society of Hematology, 11/15/2022
• Clinical Characteristics, Survival Outcomes, and Prognostic Factors in Primary Cutaneous CD30+ T-Cell Lymphoma: National Cancer Database Analysis (2004-2018)
  Firas Baidoun, Jason Sluzevich, Han W Tun, Muhamad Alhaj Moustafa, American Society of Hematology, 11/15/2022
• Comprehensive Salvage Radiotherapy for Limited Relapsed B-Cell Non-Hodgkin Lymphoma Following CD19 Chimeric Antigen Receptor T-Cell Therapy
  O Saifi, W Breen, SC Lester, WG Rule, BJ Stish, A Rosenthal, J Munoz, Y Lin, N Bennani, J Paludo, A Khurana, J Villasboas Bisneto, P Johnston, SM Ansell, M Iqbal, M Al..., International Journal of Radiation Oncology, Biology, Physics, 11/1/2022
• Impact of ABO mismatch on survival and engraftment in haploidentical hematopoietic stem cell transplantation
  BJ McCormick, R Mohty, M Alhaj Moustafa, M Iqbal, R Parrondo, E Ayala, J Foran, V Roy, B Savani, MA Kharfan-Dabaja, HS Murthy, BONE MARROW TRANSPLANTATION, 11/1/2022
• 37P Obesity and ovarian cancer: A controversial risk factor
  F Baidoun, J Abdeldayem, AM Saad, MT Sarmini, MM Gad, M Alhaj Moustafa, Annals of Oncology, 6/1/2022
• In-field recurrences in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) bridged with radiation prior to CD19 chimeric antigen receptor T-cell therapy (CART).
  mran Saifi, William Breen, Scott Lester, William G. Rule, Brad J. Stish, Allison Claire Rosenthal, Javier Munoz, Yi Lin, Nabila Nora Bennani, Jonas Paludo, Arushi Khur..., 2022 ASCO Annual Meeting, 6/2022
• Combined modality therapy for early-stage Hodgkin lymphoma in the PET era: A real-world study.
  Karan Chohan, Jason R. Young, Scott Lester, Muhamad Alhaj Moustafa, Allison Claire Rosenthal, Han W. Tun, Bradford Hoppe, Patrick B. Johnston, Ivana N. M. Micallef, Th..., 2022 ASCO Annual Meeting, 6/2022
• Real-world Utilization and Cost-effectiveness of Yttrium-90 Ibritumomab Tiuxetan vs Bendamustine Plus Rituximab for FL and MZL
  Muhamad Alhaj Moustafa, MD, Bijan J Borah, PHD, James P Moriarty, MS, Ruchita Dholakia, MS, MBA, Liuyan Jiang, MD, Bradford Hoppe, MD, MPH, Jennifer Peterson, MD, Jame..., American Society of Hematology, 12/13/2021
• Characteristics, Management and Outcomes of Patients with Intravascular Lymphoma: A Mayo Clinic Experience
  Karan Seegobin, MBBS, Muhamad Alhaj Moustafa, MD, Umair Majeed, MBBS, Liuyan Jiang, MD, David Menke, MD, Ke Li, MD, Mohamed A. Kharfan-Dabaja, MD, MBA, Ernesto Ayala, ..., American Society of Hematology, 12/11/2021
• Diffuse large B-cell lymphoma with leukemic involvement.
  Justin J. Kuhlman, Muhamad Alhaj Moustafa, Karan Seegobin, Madiha Iqbal, Ernesto Ayala, Stephen M. Ansell, Allison Claire Rosenthal, Jonas Paludo, Ivana N. M. Micallef..., American Society of Clinical Oncology, 5/28/2021
• Salvage therapies in transplant-eligible relapsed classic Hodgkin lymphoma, are novel regimens better?
  Sanjal Desai, Yucai Wang, Allison Claire Rosenthal, Craig B. Reeder, David James Inwards, Ernesto Ayala, Grzegorz S. Nowakowski, Han W. Tun, Jonas Paludo, Jose Caetano..., American Society of Clinical Oncology, Virtual, 5/28/2021
• Daratumumab Plus Lenalidomide and Dexamethasone (DRd) Compared to Daratumumab Plus Pomalidomide and Dexamethasone (DPd) in Relapsed Lenalidomide-Exposed or Refractory ...
  Muhamad Alhaj Moustafa, MD, Ricardo Parrondo, MD, Mays F Abdulazeez, MBBS, Vivek Roy, MD, Taimur Sher, MD, Victoria R. Alegria, Rahma M Warsame, MD, Jeremy Larsen, Wil..., AMerican Society of hematology, 11/5/2020
• Efficacy of Daratumumab (Dara)-Based Regimens for the Treatment of Plasma Cell Leukemia (PCL)
  Ricardo Parrondo, MD, Muhamad Alhaj Moustafa, MD, Craig B. Reeder, MD, Taimur Sher, MD, Vivek Roy, MD, Rahma M Warsame, MD, Victoria R. Alegria, Wilson I Gonsalves, MD..., American Society of Hematology, 11/5/2020
• CD68+ Tumor Associated Macrophages Have Significant Impact on Therapeutic Outcome in Newly Diagnosed Multiple Myeloma (MM)
  Ricardo Parrondo, MD, Muhamad Alhaj Moustafa, MD, Han W. Tun, MD, Liuyan Jiang, MD, American Society of Hematology, 11/5/2020
• Identifying areas for quality improvement through outpatient mortality review
  Denise Gococo-Benore, Adam McLain Kase, Umair Majeed, Muhamad Alhaj Moustafa, Ruqin Chen, Sree Battu, Molly Kilpatrick, Maisha Robinson, Jennifer Cowart, Alvaro Moreno..., ASCO 2020 - QUALITY, SAFETY, AND IMPLEMENTATION SCIENCE, Virtual, 10/10/2020
• Identifying areas for quality improvement through outpatient mortality review
  Denise Gococo-Benore, Adam McLain Kase, Umair Majeed, Muhamad Alhaj Moustafa, Ruqin Chen, Sree Battu, Molly Kilpatrick, Maisha Robinson, Jennifer Cowart, Alvaro Moreno..., Journal of Clinical Oncology, 10/10/2020
• AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR DOUBLE HIT LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
  Omran Saifi, Muhamad Alhaj Moustafa, MD, Tea Reljic, Madiha Iqbal, MD, Ernesto Ayala, MD, Ambuj Kumar, Mohamed Kharfan-Dabaja, MD, the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT 2020), Madrid, Spain, 3/22/2020
• Autologous Stem Cell Transplant for Waldenström Macroglobulinemia in the Era of Novel Therapies: Still an Underutilized Tool?
  Ricardo D. Parrondo, MD, Muhamad Alhaj Moustafa, MD, Prashant Kapoor, MD, Vivek Roy, MD, Craig Reeder, MD, Sikander Ailawadhi, MD, Transplantation and Cellular Therapy Meeting, World Center Marriott in Orlando, FL, 2/19/2020
• A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalid...
  Anthony R. Mato, MD MSCE, Stephen J Schuster, MD, Francine M. Foss, MD4, Iris Isufi, MD, Wei Ding, MD, PhD, Danielle M. Brander, MD, Andrea Sitlinger, MD, Han W. Tun, ..., American Society of Hematology, Orlando, FL, 12/9/2019
• Long-Term Outcome of Patients with Low-Grade Follicular Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience
  Muhamad Alhaj Moustafa, MD, Ricardo Parrondo, MD, Gregory Wiseman, MD, Jennifer Peterson, MD, Thomas E. Witzig, MD, Han W. Tun, MD, American Society of Hematology, Orlando, 12/8/2019
• Phase I Trial of Ibrutinib, Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
  Sikander Ailawadhi, MD, Aneel Paulus, MD, Victoria R. Alegria, Betsy Laplant, MS, Muhamad Alhaj Moustafa, MD, Dustin Chapin, Keisha Jackson, Prachi Jani, MD, Salman Ah..., American Society of Hematology, Orlando, FL, 12/7/2019
• Long-Term Outcome of Patients with Marginal Zone Non-Hodgkin Lymphoma (MZL) Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience
  Muhamad Alhaj Moustafa, MD, Ricardo Parrondo, MD, Gregory Wiseman, MD, Jennifer Peterson, MD, Thomas E. Witzig, MD, Han W. Tun, MD, American Society of Hematology, Orlando, FL, 12/7/2019
• Back to the basics: Etoposide neurotoxicity in a patient with high grade B-cell lymphoma
  Muhamad Alhaj Moustafa, MD, Taimur Sher, MD, THE 2019 FLASCO BUSINESS OF ONCOLOGY SUMMIT AND SPRING SESSION, Orlando, FL, 4/12/2019
• Join now to see all

Lectures

• Updates in the management of diffuse large B cell lymphoma 
  The 4th International Oncology Summit 2023 - American Hospital in Dubai and Mayo Clinic - 4/30/2023
• Updates in Lymphoma 
  6th Annual Hematology/Oncology Challenges and Advances in Patient Care for NPs, PAs, and Nurses 2023 - 4/15/2023
• Best of ASH 2022-Updated about Lymphoma from ASH 2022 
  Mayo Clinic Florida Cancer Center Grand Round - 1/27/2023
• Commonly used treatments in Lymphoma 
  Lymphoma Educational Series - Mayo Clinic Cancer Center - 1/11/2023
• Finding Your Niche in Oncology: Careers in Academia 
  American Society of Clinical Oncology Meeting - 6/2022
• Pola-R-CHP vs. R-CHOP 
  FLASCO Spring Session in Orlando - 5/7/2022
• Advances in Blood Cancer Treatments at Mayo Clinic in Florida 
  2/16/2022
• Lymphoma-Low Grade (One hour presentation to patients and care givers) 
  Virtual Florida Blood Cancer Conference by The Leukemia and Lymphoma Society - 2/12/2022
• Real-world Utilization and Cost-effectiveness of Yttrium-90 Ibritumomab Tiuxetan vs Bendamustine Plus Rituximab for FL and MZL 
  Virtual - 11/16/2021
• Real-World Comparison of DRd and DPd for Relapsed/Refractory MM 
  12/10/2020
• Long-Term Outcome of Patients with Marginal Zone Non-Hodgkin Lymphoma (MZL) Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/8/2019
• Long-Term Outcome of Patients with Marginal Zone Non-Hodgkin Lymphoma (MZL) Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Pre-clinical evaluation of high-dose Pralatrexate for CNS lymphoma 
  The Annual International Primary CNS Lymphoma Collaborative Group Meeting - 12/6/2019
• Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response 
  Society of hematologic oncology (SOHO) - 9/19/2014
• Join now to see all

Other

• Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response 
  Alhaj Moustafa M, Rajkumar, SV, Dispenzieri, A, Buadi, F, Gertz, M, Lacy, M, Kapoor, P, Hayman, S, Dingli, D, Kyle, R, Kumar, S, Webcast Interview with The International Myeloma Foundation (IMF)
  https://www.myeloma.org/videos/dr-muhamad-alhaj-moustafa-free-light-chain-measurements-myeloma-patients-ash-2014-0
  American Society of Hematology (ASH) 2014 - 12/8/2014